Investments in and Advances to Joint Ventures (Tables)

3 Months Ended

Mar. 31, 2024

Schedule of Equity Method Investments [Line Items]

Schedule of Changes to Investments in and Advances to Joint Ventures

The changes to Investments in and Advances to Joint Ventures are as follows (in thousands):

Balance, December 31, 2023	$	39,372
Equity in net loss		(153	)
Amortization of basis differentials		170
Repayment of advances		(730	)
Capitalized costs		44
Change in fair value of derivative		(96	)
Balance, March 31, 2024	$	38,607

Schedule of Reconciliation of Consolidated Joint Venture Equity

A reconciliation of the consolidated joint venture equity is as follows (in thousands):

	March 31, 2024			December 31, 2023
Company's share of accumulated equity	$	35,365		$	35,782
Basis differentials		1,367			1,099
Deferred development fees, net of portion related to the Company's interest		(132	)		(136	)
Amounts payable to the Company		2,007			2,627
Investments in and Advances to Joint Ventures, net	$	38,607		$	39,372